Per 
Medical Records - Site 19 - Project Amrita
The following medical charts represent the only records that remain from what is thought to have been more than 200 human trials involving variants of RS-Amrita. All other written material in relation to the project was lost or destroyed. The remaining records are presented in chronological order.
Subject No.: 16
Name: Brian Forbes
Age: 44
Administered: RS-Amrita A.16 - standard dosage. Delivery: intravenous. Action: anti-apoptotic.
Time elapsed: 0 days
Observations: Subject is a healthy Caucasian male of middle age. Height 5' 10". Weight 175lbs. Employed as Foundation researcher since 1935. No serious health complaints. Near-sighted in both eyes. Family history of cardiac disease.
No initial symptoms observed. Anaphylactic reaction within expected range.
Subject No.: 27
Name: Dr. Margaret Purdey
Age: 73
Administered: RS-Amrita A.14 - half dosage. Delivery: oral. Action: immunostimulant.
Subject No.: 139
Name: Stephen Moore
Age: 52
Administered: RS-Amrita A.19 - double dosage. Delivery: ocular. Action: unknown (Foundation variant of folkloric "invulnerability potion").
Subject No.: 152
Time elapsed: 4 days
Observations: Subject reports increased positive emotions. Hormone levels within normal range. Potential placebo effect?
Subject No.: 194
Time elapsed: 35 days
Observations: Blood tests indicate elevated white cell count. No further symptoms.
Time elapsed: 82 days
Observations: Subject reports low-level generalised pain throughout body. No other symptoms reported or observed.
Subject No.: 85
Name: <illegible>
Age: 22
Administered: RS-Amrita A.12 - standard dosage. Delivery: intravenous. Action: thaumatergic (temporal dampening).
Time elapsed: 0 days
Observations: Immediate symptoms of low cardiac rate without reduction in blood pressure, as anticipated. Oxygen applied. Normal heart rate restored as substance is distributed to the tissues.
When asked to confirm consciousness, subject appeared confused, stating that they had not experienced adverse symptoms.
Subject No.: 58
Name: Simon Wang
Age: 39
Administered: RS-Amrita B.08 - standard dosage. Delivery: oral. Action: stem cell growth hormone (extracted from anomalous Rosaceae species).
Time elapsed: 0 days
Observations: No initial symptoms observed. Subject reports RS-Amrita "tastes like blood".
